These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 23375872)

  • 1. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization.
    Schurgers LJ; Uitto J; Reutelingsperger CP
    Trends Mol Med; 2013 Apr; 19(4):217-26. PubMed ID: 23375872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gla-rich protein acts as a calcification inhibitor in the human cardiovascular system.
    Viegas CS; Rafael MS; Enriquez JL; Teixeira A; Vitorino R; Luís IM; Costa RM; Santos S; Cavaco S; Neves J; Macedo AL; Willems BA; Vermeer C; Simes DC
    Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):399-408. PubMed ID: 25538207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix Gla-protein: the calcification inhibitor in need of vitamin K.
    Schurgers LJ; Cranenburg EC; Vermeer C
    Thromb Haemost; 2008 Oct; 100(4):593-603. PubMed ID: 18841280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms mediating vascular calcification: role of matrix Gla protein.
    Proudfoot D; Shanahan CM
    Nephrology (Carlton); 2006 Oct; 11(5):455-61. PubMed ID: 17014561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin K for the Treatment of Cardiovascular Disease in End-Stage Renal Disease Patients: Is there Hope?
    Roumeliotis S; Roumeliotis A; Dounousi E; Eleftheriadis T; Liakopoulos V
    Curr Vasc Pharmacol; 2021; 19(1):77-90. PubMed ID: 32196451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review.
    Roumeliotis S; Dounousi E; Eleftheriadis T; Liakopoulos V
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of arterial calcification corrects the low bone mass phenotype in MGP-deficient mice.
    Marulanda J; Gao C; Roman H; Henderson JE; Murshed M
    Bone; 2013 Dec; 57(2):499-508. PubMed ID: 23994172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Matrix Gla protein as natural inhibitor of vascular calcification and potential treatment target].
    Mayer O
    Cas Lek Cesk; 2016; 155(4):13-6. PubMed ID: 27481196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differentially expressed genes in human varicose veins: involvement of matrix gla protein in extracellular matrix remodeling.
    Cario-Toumaniantz C; Boularan C; Schurgers LJ; Heymann MF; Le Cunff M; Léger J; Loirand G; Pacaud P
    J Vasc Res; 2007; 44(6):444-59. PubMed ID: 17643059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging Role of Vitamins D and K in Modulating Uremic Vascular Calcification: The Aspect of Passive Calcification.
    Hou YC; Lu CL; Zheng CM; Chen RM; Lin YF; Liu WC; Yen TH; Chen R; Lu KC
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30642029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vitamin K2 supplementation on functional vitamin K deficiency in hemodialysis patients: a randomized trial.
    Westenfeld R; Krueger T; Schlieper G; Cranenburg EC; Magdeleyns EJ; Heidenreich S; Holzmann S; Vermeer C; Jahnen-Dechent W; Ketteler M; Floege J; Schurgers LJ
    Am J Kidney Dis; 2012 Feb; 59(2):186-95. PubMed ID: 22169620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation and potential diagnostic value of circulating matrix Gla protein (MGP) species.
    Cranenburg EC; Koos R; Schurgers LJ; Magdeleyns EJ; Schoonbrood TH; Landewé RB; Brandenburg VM; Bekers O; Vermeer C
    Thromb Haemost; 2010 Oct; 104(4):811-22. PubMed ID: 20694284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of vitamin K in soft-tissue calcification.
    Theuwissen E; Smit E; Vermeer C
    Adv Nutr; 2012 Mar; 3(2):166-73. PubMed ID: 22516724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Warfarin induces cardiovascular damage in mice.
    Krüger T; Oelenberg S; Kaesler N; Schurgers LJ; van de Sandt AM; Boor P; Schlieper G; Brandenburg VM; Fekete BC; Veulemans V; Ketteler M; Vermeer C; Jahnen-Dechent W; Floege J; Westenfeld R
    Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2618-24. PubMed ID: 23990204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells--a cell system which resembles the system in bone cells.
    Wallin R; Cain D; Sane DC
    Thromb Haemost; 1999 Dec; 82(6):1764-7. PubMed ID: 10613667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification.
    Schurgers LJ; Spronk HM; Skepper JN; Hackeng TM; Shanahan CM; Vermeer C; Weissberg PL; Proudfoot D
    J Thromb Haemost; 2007 Dec; 5(12):2503-11. PubMed ID: 17848178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of Vitamin K-Dependent Proteins in Vascular Calcification.
    Tesfamariam B
    J Cardiovasc Pharmacol Ther; 2019 Jul; 24(4):323-333. PubMed ID: 30905168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoxyl sulfate promotes osteogenic differentiation of vascular smooth muscle cells by miR-155-5p-dependent downregulation of matrix Gla protein via ROS/NF-κB signaling.
    He X; Wang Z; Wei L; Cheng X; Chen L; Gao F; Jiang H
    Exp Cell Res; 2020 Dec; 397(1):112301. PubMed ID: 32979364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating species of matrix Gla protein and the risk of vascular calcification in healthy women.
    Dalmeijer GW; van der Schouw YT; Magdeleyns EJ; Vermeer C; Elias SG; Velthuis BK; de Jong PA; Beulens JW
    Int J Cardiol; 2013 Oct; 168(6):e168-70. PubMed ID: 24029658
    [No Abstract]   [Full Text] [Related]  

  • 20. CALU polymorphism A29809G affects calumenin availability involving vascular calcification.
    Jover E; Marín F; Quintana M; Pérez-Andreu J; Hurtado JA; Rodríguez C; Martínez-González J; González-Conejero R; Valdés M; Hernández-Romero D
    J Mol Cell Cardiol; 2015 May; 82():218-27. PubMed ID: 25823396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.